First drug to delay onset of type 1 diabetes made available on NHS
The NHS in England and Wales has introduced Teplizumab, the first drug capable of delaying the onset of type 1 diabetes. This immunotherapy treatment can provide patients with three additional years before requiring daily insulin management.
Why it matters
This represents a significant medical breakthrough for patients and families, potentially reducing the long-term burden of managing a chronic, life-altering condition.
Image source, Family photo Image caption, Theo Sebastian-Jenkin was diagnosed with type 1 diabetes as a young boy after displaying extreme fatigue, weight loss and other symptoms
The article is a straightforward health news report focusing on medical advancements and patient impact.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in